Related Articles
ACR Winter Rheumatology Symposium: Tips for ANCA Testing
How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests
Case Report: Hydralazine-Induced ANCA-Associated Vasculitis
Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus. Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, serositis, myalgias and/or hepatomegaly. Features…
The Granulomatosis of Wegener’s
Delving deeper into the nonvasculitis aspects of the disease
Reading Rheum
Handpicked Reviews of Contemporary Literature